Ann Dobry, DO
Obstetrics & Gynecology · Stockbridge, GANPI 1669867297
Payments from drug & device makers
Across 94 payments — averaging $18.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$341
- Mayne Pharma Commercial LLC$254
- Astellas Pharma US Inc$179
- Daiichi Sankyo Inc.$144
- Organon$126
- Intuitive Surgical$95
- plus $617 from 16 others
What the payments were for
- Food & beverage$1,755100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $341 |
| Mayne Pharma Commercial LLC | 13 | $254 |
| Astellas Pharma US Inc | 10 | $179 |
| Daiichi Sankyo Inc. | 6 | $144 |
| Organon | 9 | $126 |
| Intuitive Surgical | 1 | $95 |
| Sumitomo Pharma America, Inc. | 4 | $90 |
| Exeltis, USA Inc. | 4 | $80 |
| Optumhealth Care Solutions, LLC | 4 | $74 |
| Shield Therapeutics Inc | 2 | $46 |
| Coopersurgical, Inc. | 2 | $46 |
| Biogen | 2 | $44 |
| Evofem Biosciences, Inc. | 3 | $44 |
| Merck | 2 | $35 |
| Mylan Pharmaceuticals Inc. | 2 | $29 |
| Bayer | 1 | $29 |
| Dexcom, Inc. | 1 | $22 |
| BD | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Scynexis, Inc. | 1 | $14 |
| Therapeuticsmd, Inc. | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $13 |
How this compares
$1,755 in reported general payments places this provider in the 65th percentile of 1,324 obstetrics & gynecology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $633 |
| Clobetasol Propionate | 11 | $143 |
| Medroxyprogesterone Acetate | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Stockbridge
- Laxman RamaniStockbridge$14K
- Elisheba ButtsStockbridge$13K
- Gretchen MitchellCumming$4.5M
- Stephen BlankAtlanta$3.5M
- Eric BrownAtlanta$1.7M
- Melissa KottkeAtlanta$1.7M
- Allan DinnersteinFort Stewart$1.5M
- David MontaldiMarietta$1.1M
- Winifred SoufiAtlanta$889K
- Richard ZaneAlpharetta$638K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.